Lasmiditan is an effective acute treatment for migraine: A phase 3 randomized study

OBJECTIVE: To assess the efficacy and safety of lasmiditan in the acute treatment of migraine. METHODS: Adult patients with migraine were randomized (1:1:1) to a double-blind dose of oral lasmiditan 200 mg, lasmiditan 100 mg, or placebo and were asked to treat their next migraine attack within 4 hou...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuca, Bernice, Silberstein, Stephen D., Wietecha, Linda, Berg, Paul H., Dozier, Gregory, Lipton, Richard B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6329326/
https://www.ncbi.nlm.nih.gov/pubmed/30446595
http://dx.doi.org/10.1212/WNL.0000000000006641

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6329326/
https://www.ncbi.nlm.nih.gov/pubmed/30446595
http://dx.doi.org/10.1212/WNL.0000000000006641

Ejemplares similares